Didrogyl is developed by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

What development phase is Didrogyl in?

Didrogyl is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Didrogyl

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · FDA-approved active Small molecule Quality 2/100

Generic name	Didrogyl
Sponsor	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

No approved indications tracked.

No common side effects on file.

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results